InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by INGRAM ROBERT ALEXANDER. Officer active across 2 companies, notably Biocryst Pharmaceuticals INC. Aggregated, 17 disclosures have been published. The latest transaction was filed on 17 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
€16,3568,498 shares@ €1.92470.012% mcap13.4% of flow
Common Stock
SEC:0001415889-22-006739:0·
012,866 shares0
Common Stock
SEC:0001127602-22-017165:0·
€18,0232,078 shares@ €8.67330.0011% mcap13.8% of flow
Common Stock
SEC:0001127602-22-016390:0·
€15,7675,795 shares@ €2.72080.011% mcap13.0% of flow
Common Stock
SEC:0001415889-22-003184:0·
€16,7571,128 shares@ €14.85550.0010% mcap12.8% of flow
Common Stock
SEC:0001127602-22-007725:0·
€15,4423,296 shares@ €4.68534.5% of flow
Common Stock
SEC:0001415889-21-006070·
€15,4423,296 shares@ €4.6850.011% mcap12.7% of flow
Common Stock
SEC:0001415889-21-006070:0·
€16,5951,554 shares@ €10.67880.0010% mcap34.7% of flow
Common Stock
SEC:0001127602-21-030043·
€16,5951,554 shares@ €10.67880.0010% mcap12.7% of flow
Common Stock
SEC:0001127602-21-030043:0·
€15,7241,869 shares@ €8.41335.1% of flow
Common Stock
SEC:0001415889-21-004540·
€15,7241,869 shares@ €8.4130.011% mcap12.9% of flow
Common Stock
SEC:0001415889-21-004540:0·
€15,8661,177 shares@ €13.47980.0010% mcap33.2% of flow
Common Stock
SEC:0001127602-21-024776·
€15,8661,177 shares@ €13.47980.0010% mcap12.2% of flow
Common Stock
SEC:0001127602-21-024776:0·
€13,6421,255 shares@ €10.870130.4% of flow
Common Stock
SEC:0001104659-21-084242·
€13,6421,255 shares@ €10.87010.0099% mcap11.2% of flow
Common Stock
SEC:0001104659-21-084242:0·
€15,3651,188 shares@ €12.93350.0009% mcap32.1% of flow
Common Stock
SEC:0001127602-21-018501·
€15,3651,188 shares@ €12.93350.0009% mcap11.8% of flow
Common Stock
SEC:0001127602-21-018501:0·
17 of 17 declarations
About INGRAM ROBERT ALEXANDER
Robert Alexander Ingram is an executive at Biocryst Pharmaceuticals Inc.
